Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Cardiac Pacemaker Market, published by KBV research, The Global Cardiac Pacemaker Market size is expected to reach $8.0 billion by 2024, rising at a market growth of 6.8% CAGR during the forecast period.
The Implantable Cardiac Pacemakers market dominated the Global Cardiac Pacemaker Market by Product 2017, thereby, achieving a market value of $5,019.2 million by 2024, The External Cardiac Pacemaker market is expected to witness highest CAGR of 7.7% during (2018 - 2024).
The North America market would dominate the Global Single-Chamber Cardiac Pacemakers Market by Region 2024 growing at a CAGR of 5.5 % during the forecast period. The Europe market is expected to witness a CAGR of 5.8% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.5% during (2018 - 2024).
The North America market dominated the Global Ambulatory Surgery Centers (ASCs) Cardiac Pacemaker Market by Region 2017, growing at a CAGR of 5.7 % during the forecast period. The Europe market is expected to witness a CAGR of 6.1% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 7.7% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd. and Medline Industries, Inc.
Global Cardiac Pacemaker Market Segmentation
By End User
Unique Offerings from KBV Research